TAYLOR CORUM: Open Payments
NPI 1992438329 · LILLINGTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,236 in 108 payments from 16 companies in 2025. Trend: 2023 $1,634 · 2024 $2,281 · 2025 $2,236
Food & beverage: $2,146Education: $90
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 30 | $436 |
| ABBVIE INC. | 17 | $396 |
| GlaxoSmithKline, LLC. | 10 | $219 |
| Novartis Pharmaceuticals Corporation | 9 | $191 |
| Janssen Biotech, Inc. | 6 | $184 |
| UCB, Inc. | 7 | $155 |
| Mallinckrodt Hospital Products Inc. | 6 | $138 |
| AstraZeneca Pharmaceuticals LP | 6 | $114 |
| Fresenius Kabi USA, LLC | 4 | $90 |
| Organon LLC | 3 | $79 |
Products named: SKYRIZI, BENLYSTA, OTEZLA, COSENTYX, TREMFYA, KRYSTEXXA, Bimzelx, RINVOQ.
Industry payments across NC — which companies pay providers there.
